Author

Taina Sipponen 1

1 Clinic Of Gastroenterology, Department Of Medicine, Helsinki University Central Hospital, Helsinki , Finland

CORRELATION BETWEEN FAECAL CALPROTECTIN AND LEWIS SCORE IN SMALL-BOWEL CAPSULE ENDOSCOPY; A MULTICENTRE STUDY

Anastasios Koulaouzidis, Taina Sipponen, Ervin Toth, Richard Makins, Uri Kopylov, Leonidas Bartzis, Artur Németh, Gabriele Johansson, Moshe Nadler, Abraham (Rami) Eliakim, Ernest Seidman, John Nicholas Plevris

CYCLOSPORIN A IN ACUTE STEROID-REFRACTORY OR DEPENDENT ULCERATIVE COLITIS: A PROSPECTIVE STUDY ON LONG TERM OUTCOME

Urpo Nieminen, Ulla Turunen, Perttu Arkkila, Taina Sipponen, Clas-Göran af Björkesten, Martti A. Färkkila

DISCONTINUATION OF INFLIXIMAB THERAPY IN PATIENTS WITH CROHN’S DISEASE IN SUSTAINED, COMBINED CLINICAL-BIOCHEMICAL-ENDOSCOPIC REMISSION: A DOUBLE-BLINDED, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIAL

Sine Buhl, Casper Steenholdt, Jens Frederik Dahlerup, Tobias Wirenfeldt Klausen, Mark Andrew Ainsworth, Jørgen Jahnsen, Jørn Brynskov, Ole Østergaard Thomsen, Katrine Risager Christensen, Akbar Molazahi, Natalia Pedersen, Niels Thorsgaard, Eva Efsen Dahl, Ida Vind, Hendrika Adriana Linda Kievit, Taina Sipponen, Jan Marsal;;

Drug monitioring: When does it help in planning therapy?

Taina Sipponen

EVALUATION OF CONCOMITANT CORTICOSTEROID AND VEDOLIZUMAB USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) IN REAL-LIFE CLINICAL PRACTICE 

Taina Sipponen

EVALUATION OF CONCOMITANT CORTICOSTEROID AND VEDOLIZUMAB USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) IN REAL-LIFE CLINICAL PRACTICE 

Tero Ylisaukko-oja, Jaakko Aaltonen, Saku Torvinen, Heikki Nuutinen, Timo Blomster, Airi Jussila, Markku Pajala, Jari Jokelainen, Sauli Herrala, Klaus Tamminen, Taina Sipponen

Gut microbiota composition as a predictor of infliximab treatment response in inflammatory bowel disease patients

Eija Nissilä, Rebecka Ventin-Holmberg, Taina Sipponen, Anne Salonen, Päivi Saavalainen

PREDICTING THE OUTCOME AFTER DISCONTINUATION OF TNFΑ –BLOCKING AGENTS IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH DEEP REMISSION

Pauliina Molander, Johanna Haapamäki, Kimmo Salminen, Helena Kemppainen, Henna Rautiainen, Urpo Nieminen, Perttu Arkkila, Timo Markus Blomster, Ritva Koskela, Markku Nissinen, Airi Jussila, Juha Kuisma, Jari Punkkinen, Kaija-Leena Kolho, Harri Mustonen, Martti A. Färkkila, Taina Sipponen

SERUM INFLIXIMAB CONCENTRATIONS DURING INDUCTION PREDICT SHORT-TERM TREATMENT RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Anja Eberl, Sami Qadri, Päivi Saavalainen, Taina Sipponen

Item 1 - 9 / 20
1
2